These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18606253)

  • 21. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Anti-C1q Autoantibodies by Western Blot.
    Verlemyr A; Truedsson L; Skattum L
    Methods Mol Biol; 2019; 1901():183-189. PubMed ID: 30539577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
    Mevorach D
    Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies against complement C1q in acute post-streptococcal glomerulonephritis.
    Kozyro I; Korosteleva L; Chernoshej D; Danner D; Sukalo A; Trendelenburg M
    Clin Immunol; 2008 Sep; 128(3):409-14. PubMed ID: 18544473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
    Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M
    Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insight into the autoimmunogenicity of the complement protein C1q.
    Stoyanova V; Petrova S; Tchorbadjieva M; Deliyska B; Vasilev V; Tsacheva I
    Mol Immunol; 2011 Jan; 48(4):678-82. PubMed ID: 21159384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis.
    Trouw LA; Daha MR
    Expert Opin Biol Ther; 2005 Feb; 5(2):243-51. PubMed ID: 15757386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ecchymotic angioedema revealing childhood systemic lupus erythematosus with anti-C1q antibodies].
    Frot AS; Barbarot S; Poignant S; Guyot C; Stalder JF
    Ann Dermatol Venereol; 2008; 135(8-9):584-6. PubMed ID: 18789294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein.
    Yang XW; Tan Y; Yu F; Zhao MH
    Hum Immunol; 2012 Feb; 73(2):156-63. PubMed ID: 22192784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example].
    Trendelenburg M; Schifferli JA
    Praxis (Bern 1994); 1998 Dec; 87(51-52):1811-3. PubMed ID: 10025155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.
    Arason GJ; Kolka R; Hreidarsson AB; Gudjonsson H; Schneider PM; Fry L; Arnason A
    Clin Exp Immunol; 2005 Jun; 140(3):572-9. PubMed ID: 15932521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus].
    Trendelenburg M; Schifferli JA
    Z Rheumatol; 2000 Jun; 59(3):172-5. PubMed ID: 10929445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of Anti-C1q Antibodies in Egyptian Systemic Lupus Erythematosus Patients.
    Eldin RE; Marie MA
    Saudi J Kidney Dis Transpl; 2022; 33(1):66-71. PubMed ID: 36647980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.
    Trouw LA; Groeneveld TW; Seelen MA; Duijs JM; Bajema IM; Prins FA; Kishore U; Salant DJ; Verbeek JS; van Kooten C; Daha MR
    J Clin Invest; 2004 Sep; 114(5):679-88. PubMed ID: 15343386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice.
    Cortes-Hernandez J; Fossati-Jimack L; Petry F; Loos M; Izui S; Walport MJ; Cook HT; Botto M
    Eur J Immunol; 2004 Dec; 34(12):3713-22. PubMed ID: 15517607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
    Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL
    Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C1q, antibodies and anti-C1q autoantibodies.
    Beurskens FJ; van Schaarenburg RA; Trouw LA
    Mol Immunol; 2015 Nov; 68(1):6-13. PubMed ID: 26032012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical analysis of the epitope specificities of anti-C1q autoantibodies accompanying human lupus nephritis reveals them as a dynamic population in the course of the disease.
    Stoyanova V; Tchorbadjieva M; Deliyska B; Vasilev V; Tsacheva I
    Immunol Lett; 2012; 148(1):69-76. PubMed ID: 22981967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.